Released on: June 18, 2015, 3:28 am (EDT)
Author: MIKE KERWIEN
Industry: Construction, Small Business
WILMINGTON, DE, June 18, 2015 — /EPR NETWORK/ — M. Davis, the fifth generation woman-owned Industrial Contractor and Fabricator headquartered in Wilmington, DE has named Christina MacMillan its Manager of Supplier Diversity. Christina MacMillan will enhance the program by working with diverse vendors to help identify opportunities with M. Davis. This will enable M. Davis to continue promoting economic growth and community development through our diversity and inclusion initiatives while also expanding our current supplier base to include the best and brightest.
Released on: May 20, 2013, 7:28 am
Author: M-CAT Enterprises
M-CAT’s CEO Anyck Turgeon Attests to 400% Trend Increase In U.S.-Based Chemical Incidents Since 2010
Austin, TX, May 20, 2013, 7:28 am — /EPR NETWORK/ — As a result of on-site preliminary assessment performed by global security expert Anyck Turgeon, M-CAT Enterprises (M-CAT) is releasing three informational resources to help raise the understanding and awareness of chemical safety issues: i) a Firestorm interview revealing initial alarming on-site findings ii) a comprehensive article exposing the economics of poor chemical security practices and providing ten easily implemented recommendations iii) link to a live interview on May 29, 2013 to address other security challenges and best practices towards fire avoidance in manufacturing and/or storage facilities containing toxic and explosive chemicals such as fertilizers.
Released on: February 22, 2013, 7:20 am
Author: Worlmald Australia
February 22, 2013, 7:20 am — /EPR NETWORK/ — As many Australians take to the water to enjoy the long warm summer days, fire protection specialist Wormald is urging watercraft owners and operators to ensure they have adequate fire protection equipment on board.
Released on: January 22, 2013, 11:46 am
Author: Biosortia Pharmaceuticals
Industry: Biotech, Healthcare, Chemicals, Pharmaceuticals
Biosortia Pharmaceuticals Hires Kurt Dieck as President and CEO to Accelerate Strategy to Develop and License New Highly Active Compounds from Unculturable Aquatic Microbial Consortia
Dublin, Ohio, January 22, 2013, 11:46 am — /EPR NETWORK/ — Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November 2012 and has quickly identified other key executives, including Dr. Guy Carter, former Natural Product head at Wyeth Pharmaceuticals, as his Chief Science Officer. In conjunction, other collaboration partners have joined the team, including NOAA (National Oceanic and Atmospheric Administration), NCI (National Cancer Institute) and key universities, to strategically accelerate the development of novel drug leads in the therapeutic areas of cancer, infectious diseases, inflammation and neurological disorders. Biosortia Pharmaceuticals has seen promising early results with dozens of novel compounds having already been requested, and are under evaluation with NCI and Eli Lilly.
Released on: May 29, 2012, 3:24 am
Author: Chris Hebel
Hangzhou, China, May 29, 2012, 3:24 am — /EPR NETWORK/ — In a new study published online in Nature Communications, researchers from Sichuan Agricultural University and LC Sciences report the miRNAome in porcine adipose and muscle tissues. The report provides a valuable epigenomic source for obesity prediction and prevention and furthers the development of pig as a model organism for human obesity research1.
Released on: May 01, 2012, 6:08 pm
Author: EnviroSelects LLC
May 01, 2012, 6:08 pm — /EPR NETWORK/ — Bleach is a strong irritant, frequently linked to newly-acquired asthma. A recent decision by Compass Children’s Center in San Francisco to use exclusively “bleach-free” cleaning products resulted in visibly less asthmatic symptoms in both children and childcare workers.
Released on: February 13, 2012, 2:57 am
Author: Hygiene Worldwide
Tunis, Tunisia – The Tunisian government and the UK-based company Hygiene Worldwide are working together to provide a range of unique, world-leading hygiene products throughout the Tunisian Public Health Service. Successful implementation will further promote Tunisian economic growth with the establishment of Tunisia as a major distribution and production hub.
Released on: January 25, 2012, 10:55 pm
Author: Advinus Therapeutics Limited
BANGALORE, INDIA and Vancouver, B.C., CANADA – Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started working on 15 programs based on SignalChem’s proprietary Kinase platform for targeted therapies in oncology. Each program is being developed with corresponding diagnostics and tracers for patient selection and biomarkers for follow up offering the right treatment to the right patient at the right time. The companies have received a very high level of interest from pharma companies to license and collaborate on the programs and therefore see a rapid progression to the clinic.